Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13–15 June, 2006
Open Access
- 24 April 2007
- journal article
- Published by Springer Science and Business Media LLC in Kinetoplastid Biology and Disease
- Vol. 6 (1), 3
- https://doi.org/10.1186/1475-9292-6-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Immunotherapy for Drug‐Refractory Mucosal LeishmaniasisThe Journal of Infectious Diseases, 2006
- Prevention and Treatment of Cutaneous Leishmaniasis in Primates by Using Synthetic Type D/A Oligodeoxynucleotides Expressing CpG MotifsInfection and Immunity, 2005
- Second-generation vaccines against leishmaniasisTrends in Parasitology, 2005
- Randomized, Double-Blind Clinical Trial of Topical Imiquimod 5% with Parenteral Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis in PeruClinical Infectious Diseases, 2005
- Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran.2003
- Immunotherapy of American cutaneous leishmaniasis in Venezuela during the period 1990–1999Transactions of the Royal Society of Tropical Medicine and Hygiene, 2003
- Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonialInternational Journal of Dermatology, 2002
- Successful Treatment of Drug‐Resistant Cutaneous Leishmaniasis in Humans by Use of Imiquimod, an ImmunomodulatorClinical Infectious Diseases, 2001
- A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in TurkeyInternational Journal of Dermatology, 1997
- Effect of Air Drying and Dressings on the Surface of a WoundNature, 1963